Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Valentin Skryabin"'
Autor:
Valentin Skryabin, Ilya Rozochkin, Mikhail Zastrozhin, Volker Lauschke, Johan Franck, Evgeny Bryun, Dmitry Sychev
Publikováno v:
The Pharmacogenomics Journal. 23:45-49
The study aimed to conduct a meta-analysis of studies comparing pharmacogenetically guided dosing of antidepressants with empiric standard of care. Publications referring to genotype-guided antidepressant therapy were identified via PubMed, Google Sc
Autor:
Mauro Pettorruso, Giovanni Martinotti, Stefania Chiappini, Alessio Mosca, Andrea Miuli, Maria Chiara Santovito, Valentin Skryabin, Stefano L. Sensi, Massimo Di Giannantonio
Publikováno v:
Current Pharmaceutical Design. 28:2241-2259
Background: Concurrent disorder or dual diagnosis refers to a combination of substance use disorders and mental disorders that occur in the same patient simultaneously. These conditions pose significant clinical and healthcare impacts and are often u
Autor:
Valentin Skryabin, Mikhail Zastrozhin, Alexandra Parkhomenko, Volker M. Lauschke, Valery Smirnov, Aleksey Petukhov, Elena Pankratenko, Sergei Pozdnyakov, Sergei Koporov, Natalia Denisenko, Kristina Akmalova, Evgeny Bryun, Dmitry Sychev
Publikováno v:
Current drug metabolism.
Background: Previous studies have shown that haloperidol biotransformation is mainly metabolized by CYP2D6. The CYP2D6 gene is highly polymorphic, contributing to inter-individual differences in enzymatic activity, and may impact haloperidol biotrans
Autor:
Mikhail Zastrozhin, Valentin Skryabin, Aleksey Petukhov, Elena Pankratenko, Sergei Pozdniakov, Valentina Ivanchenko, Denis Horyaev, Roman Vlasovskih, Evgeny Bryun, Dmitry Sychev
Publikováno v:
Journal of psychopharmacology (Oxford, England). 36(10)
Introduction: Selective serotonin reuptake inhibitors have a common and increasing use for the treatment of patients diagnosed with depressive disorders. Some of them do not respond adequately to therapy, and numerous previous studies have indicated
Autor:
Nicole Davis Weaver, Anna Skryabina, Jalal Arabloo, Segun Emmanuel Ibitoye, Mahaveer Golechha, Yasir Waheed, Gebiyaw Wudie Tsegaye, Akshaya Srikanth Bhagavathula, Reza Mohammadpourhodki, Simon Hay, Ilse Dippenaar, Rafael Lozano, Mostafa Dianatinasab, Valentin Skryabin, Bach Tran, Andrew Olagunju, Lorenzo Monasta, Azeem Majeed, Hamidreza Komaki, Mohamad-Hani Temsah, Abdallah Samy, Eduarda Fernandes, Shafiu Mohammed, Carlos Castañeda-Orjuela
Publikováno v:
BMC Medical Informatics and Decision Making
BMC Medical Informatics and Decision Making, Vol 21, Iss 1, Pp 1-20 (2021)
BMC Medical Informatics and Decision Making, Vol 21, Iss 1, Pp 1-20 (2021)
Background Accurate, comprehensive, cause-specific mortality estimates are crucial for informing public health decision making worldwide. Incorrectly or vaguely assigned deaths, defined as garbage-coded deaths, mask the true cause distribution. The G
Autor:
Zastrozhin, Smirnov, Petukhov, Pankratenko, Zastrozhina, Grishina, Ryzhikova, Bure, Valentin Skryabin, Vlasovskih, Bryun, Sychev
Publikováno v:
Psychopharmacol Bull
Scopus-Elsevier
Scopus-Elsevier
INTRODUCTION: Mirtazapine is commonly prescribed to patients diagnosed with major depressive disorder.Some proportion of these patients do not show adequate response to treatment regimen containing mirtazapine, whereas many of them experience dose-de
Autor:
Zastrozhin, Petukhov, Pankratenko, Grishina, Ryzhikova, Valentin Skryabin, Koporov, Bryun, Sychev
Publikováno v:
Scopus-Elsevier
Psychopharmacol Bull
Psychopharmacol Bull
INTRODUCTION: Duloxetine is commonly prescribed to patients with recurrent depressive disorder. Some part of patients in this group do not respond adequately to treatment regimen containing duloxetine, while many of them experience dose-dependent adv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::71403f180290843c43597cf37db3077c
http://www.scopus.com/inward/record.url?eid=2-s2.0-85088883922&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-85088883922&partnerID=MN8TOARS
Autor:
Zastrozhin, M. S., Valentin Skryabin, Smirnov, V., Zastrozhina, A. K., Kaverina, E. V., Klepikov, D. A., Grishina, E. A., Ryzhikova, K. A., Bure, I. V., Bryun, E. A., Sychev, D. A.
Publikováno v:
Scopus-Elsevier
Psychopharmacol Bull
Psychopharmacol Bull
INTRODUCTION: Fluvoxamine is commonly administered to patients with recurrent depressive disorder. Some of these patients do not show adequate response to the therapy with fluvoxamine, whereas many of them experience dose-dependent adverse drug react
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::849e3ed681b808a90a4b50ff677b919e
http://www.scopus.com/inward/record.url?eid=2-s2.0-85105903796&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-85105903796&partnerID=MN8TOARS